Arizona 2024 Regular Session

Arizona House Bill HB2517 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	REFERENCE TITLE: AHCCCS; obesity treatment; medication State of Arizona House of Representatives Fifty-sixth Legislature Second Regular Session 2024 HB 2517 Introduced by Representative Shah An Act amending title 36, chapter 29, article 1, Arizona Revised Statutes, by adding section 36-2907.16; relating to the Arizona health care cost containment system. (TEXT OF BILL BEGINS ON NEXT PAGE)
2	2
3	3
4	4
5	5
6	6
7	7
8	8
9	9	REFERENCE TITLE: AHCCCS; obesity treatment; medication
10	10	State of Arizona House of Representatives Fifty-sixth Legislature Second Regular Session 2024
11	11	HB 2517
12	12	Introduced by Representative Shah
13	13
14	14	REFERENCE TITLE: AHCCCS; obesity treatment; medication
15	15
16	16
17	17
18	18
19	19
20	20
21	21
22	22
23	23
24	24	State of Arizona
25	25
26	26	House of Representatives
27	27
28	28	Fifty-sixth Legislature
29	29
30	30	Second Regular Session
31	31
32	32	2024
33	33
34	34
35	35
36	36
37	37
38	38
39	39
40	40	HB 2517
41	41
42	42
43	43
44	44	Introduced by
45	45
46	46	Representative Shah
47	47
48	48
49	49
50	50
51	51
52	52
53	53
54	54
55	55
56	56
57	57
58	58
59	59
60	60
61	61
62	62
63	63
64	64	An Act
65	65
66	66
67	67
68	68	amending title 36, chapter 29, article 1, Arizona Revised Statutes, by adding section 36-2907.16; relating to the Arizona health care cost containment system.
69	69
70	70
71	71
72	72
73	73
74	74	(TEXT OF BILL BEGINS ON NEXT PAGE)
75	75
76	76
77	77
78	78	Be it enacted by the Legislature of the State of Arizona: Section 1. Title 36, chapter 29, article 1, Arizona Revised Statutes, is amended by adding section 36-2907.16, to read: START_STATUTE36-2907.16. Obesity treatment; medication; notice of coverage; definition A. The administration and its contractors shall provide comprehensive coverage to members for the treatment of obesity, including coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery and United States food and drug administration-approved antiobesity medication. Coverage criteria for United States food and drug administration-approved antiobesity medication provided under this subsection may not be more restrictive than the United States food and drug administration-approved indications for the use of those medications. B. The administration may use the system's prior authorization process to determine the medical necessity for the treatment of obesity under this section if the medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition or disorder. C. The administration shall provide notice to members regarding the coverage required by this section. The notice shall be in writing and prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to members. D. For the purposes of this section, "United States food and drug administration-approved antiobesity medication" means any medication approved by the United States food and drug administration with an indication for chronic weight management in patients with obesity.END_STATUTE
79	79
80	80	Be it enacted by the Legislature of the State of Arizona:
81	81
82	82	Section 1. Title 36, chapter 29, article 1, Arizona Revised Statutes, is amended by adding section 36-2907.16, to read:
83	83
84	84	START_STATUTE36-2907.16. Obesity treatment; medication; notice of coverage; definition
85	85
86	86	A. The administration and its contractors shall provide comprehensive coverage to members for the treatment of obesity, including coverage for prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery and United States food and drug administration-approved antiobesity medication. Coverage criteria for United States food and drug administration-approved antiobesity medication provided under this subsection may not be more restrictive than the United States food and drug administration-approved indications for the use of those medications.
87	87
88	88	B. The administration may use the system's prior authorization process to determine the medical necessity for the treatment of obesity under this section if the medical necessity determinations are made in the same manner as those determinations are made for the treatment of any other illness, condition or disorder.
89	89
90	90	C. The administration shall provide notice to members regarding the coverage required by this section. The notice shall be in writing and prominently positioned in any literature or correspondence sent to members and shall be transmitted to members within the calendar year when annual information is made available to members.
91	91
92	92	D. For the purposes of this section, "United States food and drug administration-approved antiobesity medication" means any medication approved by the United States food and drug administration with an indication for chronic weight management in patients with obesity.END_STATUTE